Given that knockdown of USP10 reduced the expression of MRPS7 and MRPS23, and considering the lack of potent antagonists targeting MRPS7 and MRPS23 directly, we investigated spautin-1, a well-characterized USP10 inhibitor with demonstrated anti-tumor effects, as a potential therapeutic agent. This evidence concerns the gene USP10 and neoplasm.